SUBSCRIBE TODAY!
Subscribing entitles a reader to complete stories on all topics released as they happen, special features, confidential documents and access to the complete, searchable story archive online back to 2004.
IP-Watch Briefs

Inside Views

Contribute your views! Submit an Inside Views idea to info [at] ip-watch [dot] ch.

We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.

Call For Transparency In The Trans-Pacific Partnership Negotiation

In this post, three US law professors explain a recent call by over 30 legal scholars for the US Trade Representative to increase transparency for the Trans-Pacific Partnership Agreement intellectual property chapter, and their response to Ambassador Kirk’s response that he is “strongly offended” by the suggestion that the negotiation is not adequately transparent already.





Latest Comments
  • David, thank you for the note. It appears there is... »
  • The link to the US proposal seems to be broken, an... »

  • For IPW Subscribers
    A guide to Geneva-based public health and intellectual property organisations. Read More >

    Monthly Reporter

    The Intellectual Property Watch Monthly Reporter, published from 2004 to January 2011, is a 16-page monthly selection of the most important, updated stories and features, plus the People and News Briefs columns.

    The Intellectual Property Watch Monthly Reporter is available in an online archive on the IP-Watch website, available for IP-Watch Subscribers.

    Access the Monthly Reporter Archive >


    WTO TRIPS Council Considers Workshop On Public Health Amendment

    Published on 2 March 2010 @ 8:30 pm

    By , Intellectual Property Watch

    The World Trade Organization group on intellectual property rights met today and ended early, discussing a potential workshop on an amendment intended to ease access to cheaper generic medicines in countries without a pharmaceutical manufacturing sector, a new proposal from Bolivia, and three separate longstanding IP issues with no major changes.

    Countries were unable to agree to hold a workshop on the so-called “paragraph 6” agreement, which allow countries to issue a compulsory licence on drugs primarily intended for export to developing countries in need of cheaper generic versions and unable to manufacture them themselves.

    Instead, the chair of the Trade-Related Aspects of Intellectual Property Rights (TRIPS) Council said he will hold informal consultations on the issue, though the details of when and how they will be conducted are not yet decided. The United States appears to be the main opponent of holding a workshop, according to several sources. For more background on this issue, see (IPW, WTO/TRIPS, 1 March 2010).

    Several countries also brought up another health issue in order to signal its continuing importance to their delegations, sources said. This issue is the delaying of generic drugs in transit through European ports, on which positions have remained unchanged since the October 2009 TRIPS Council (IPW, WTO/TRIPS, 30 October 2009).

    Also today, Martin Glass of Hong Kong was formally named the next chair of the TRIPS Council (though the decision was taken at the General Council on 22 February). A special session of TRIPS dedicated to the mandated creation of an international register on geographical indications (product names associated with a certain place and characteristics) meeting 4 March will open with its new chair, Darlington Mwape of Zambia. Karen Tan of Singapore is the outgoing chair of both meetings.

    Positions on the three longstanding TRIPS issues – which have been strategically linked and are supported by a majority of WTO members – have also remained unchanged since the October 2009 TRIPS Council, several sources told Intellectual Property Watch.

    These issues include the creation of the GI register, a proposed extension of high-level protection on geographical indications for wines and spirits to other goods (GI extension) and mandated examination of how the TRIPS agreement relates to the UN Convention on Biological Diversity.

    On the latter two issues, referred to as “outstanding implementation issues” from the Doha ministerial, WTO Director General Lamy is conducting informal consultations to try and move the process along. An open-ended informal meeting is planned in a few weeks, possibly on 12 March according to one source.

    The TRIPS Council meeting was originally scheduled for 2-3 March, but ended a day early.

    Bolivia Proposal

    Meanwhile, Bolivia has submitted a communication on the article in the TRIPS agreement related to plant variety protection and the patentability of innovations on plants and animals.

    This TRIPS Article 27.3(b) was scheduled to be reviewed four years after the implementation of the agreement forming the WTO. But that review stalled and the last official document on it [pdf] dates to March 2006.

    More recently, issues of patenting related to plant life have been discussed in relation to a mandate from the 2001 Doha ministerial that the TRIPS Council examine the relationship of TRIPS to the Convention on Biological Diversity (CBD).

    The Bolivia submission is related to the country’s adoption of a new constitution in January 2009 that includes provisions on the rights of indigenous peoples, the protection of biodiversity and “prohibition of private appropriation of plants, animals, micro-organisms and any living matter for exclusive use and exploitation.”

    Article 27.3(b) does not allow the flexibility not to grant patents on micro-organisms.

    Bolivia’s communication also cites the UN Declaration on the Rights of Indigenous Peoples, and says a review of 27.3(b) should take this declaration into account.

    It calls for 27.3(b) to prohibit the patenting of life forms, including micro-organisms and gene sequences, ensure the protection of indigenous and local community traditional knowledge and folklore in particular against IP claims over that knowledge, and prevent “anti-competitive practices” that threaten food sovereignty in developing countries.

    [Update: A WTO official has said technical cooperation was also discussed at the meeting. Bangladesh has joined Sierra Leone and Uganda in submitting its priority needs to the TRIPS Council, there is a new site at the WTO on the priority needs of least developed countries, and the EU introduced a 61-page update on its technical cooperation projects.]

    Kaitlin Mara may be reached at kmara@ip-watch.ch.

     

    Comments

    1. GenevaLunch » Blog Archive » WTO workshop cheaper generic drugs in developing countries falls through says:

      [...] Log-in International organizations ::   WTO workshop cheaper generic drugs in developing countries falls through Excerpt reprinted with permission from Intellectual Property Watch (full article) [...]

    2. TRIPS Council Discusses Efficacy Of ACTA, Public Health Amendment | Intellectual Property Watch says:

      [...] Bolivian proposal that opposes patenting life forms (IPW, WTO/TRIPS, 2 March 2010) was also briefly discussed in the TRIPS Council, participants told Intellectual Property Watch, [...]


    Leave a Reply

    We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website. By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

    We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

    By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

    1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

    2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

    3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

    4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

    5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

    6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

    7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

    8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

    9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.